tor ( target of rapamycin) signaling apr 4, 2005
TRANSCRIPT
![Page 1: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/1.jpg)
TOR ( target of rapamycin) signaling
Apr 4, 2005
![Page 2: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/2.jpg)
serine/threonine protein kinasePI-3K-kinase related kinase (PIKK)superfamily
Central role of TOR in cell growth and proliferation (disruption of gene encoding TOR results in lethality in all species)
![Page 3: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/3.jpg)
TOR: integrator of nutrient and growth factor Coordinator of cell growth and proliferation
Nutrients and Growth factor TOR
Transcription, translation and ribosome biogenesis
Cell growth (in crease in proliferating or non-proliferating cell mass and size via macromolecular biosynthesis)
Cell proliferation (increase in cell number)
Coupled, allowing cells to proliferate continuously while maintaining their size
maintain individual cells, organs and whole organisms a characteristic size(Dysregulation of TOR signaling result in pathological changes in organ size, and diseases such as
cancer, heart hypertrophy, muscular atrophy)
![Page 4: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/4.jpg)
caAkt: Constitutively active Akt
kdAkt: Kinase deficient Akt
![Page 5: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/5.jpg)
![Page 6: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/6.jpg)
Myostatin肌抑素
![Page 7: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/7.jpg)
Discovery of rapamycin and identification of TOR Structure of TOR protein TOR signaling Upstream Downstream TOR-binding proteins TOR function TOR and diseases Future directions
![Page 8: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/8.jpg)
Discovery of rapamycin and identification of TOR
1970s, rapamycin purification from Streptomyces hygroscopicus in Easter Island, antifungal activity
inhibit mammalian cell, especially immune system (B and T) cell proliferation as well as against solid tumors, potential immunosuppressant and anticancer drug
1989, FKBP12 (FK506-binding protein of 12 kDa, isomerase, protein folding) in Saccharomyces cerevisiae, direct receptor of rapamycin
1991, Genetic screens for mutations that rendered for S. cerevisiae resistant to the growth inhibitory effect of rapamycin identified two target of rapamycin proteins: TOR1 and TOR2
![Page 9: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/9.jpg)
![Page 10: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/10.jpg)
1994-1995, identification and cloning mTOR (mammalian target of rapamycin) from human rat and mouse. also named FRAP (FKBP-12-rapamycin-associated protein), RAFT (rapamycin and FKBP12 target), RAPT (rapamycin target) and SEP (sirolimus effector protein)
1999, TOR inhibitor rapamycin was approved as an immunosuppressant (inhibit kidney transplant rejection) and cardiology drug (restenosis after angioplasty 血管形成术后再狭窄 ) by FDA
rapamycin analogs CCI-779 and RAD001 are currently being tested in phase III clinical trials
An example of investigative power of “Chemical genetics” (use drugs or bioactive compounds as probes for dissection of signaling pathways)
![Page 11: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/11.jpg)
Structure of TOR protein
Large (290 kDa) evolutionarily conserved (40-60% identical among mammals, flies, worms and yeast)member of PIKK superfamily (MEC1, TEL1, RAD3, MEI41, DNA-PK, ATM, ATR and TRRAP)
HEAT repeats (Huntingtin, EF3, A subunit of PP2A and TOR motifs): 20 tandemly helical repeated, protein- protein interactionFAT (FRAP-ATM-TRRAP) and FATC (FAT C-terminus): modulation of catalytic kinase activityFRB (FKPP12-rapamycin binding domain)Kinase domainRepressor domain: auto-inhibitory domain
![Page 12: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/12.jpg)
Structure of mTOR protein
![Page 13: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/13.jpg)
![Page 14: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/14.jpg)
![Page 15: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/15.jpg)
TOR signaling (in mammalian cells)
![Page 16: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/16.jpg)
TOR upstream signaling
Growth factor/RTKIRS: insulin receptor substratePI-3K/Akt/PKBPTEN: phosphatase and tensin homologue deleted on chromosome ten (mutated in multiple advanced cancers, MMAC), a lipid phosphatasePDK1: phosphoinositide-dependent protein kinase1TSC1: tuberous sclerosis( 结节性脑硬化 ) complex 1(hamartin 错构瘤蛋白 );TSC2 : tuberin 马玲薯球蛋白
![Page 17: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/17.jpg)
![Page 18: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/18.jpg)
TOR upstream signaling
Rheb: small GTPase, TSC2 function as Rheb- GAP, shifting to Rheb-GDP;Rheb-GEF shifting to Rheb-GTP?AMPK:AMP-dependent protein kinaseLKB1: key regulator of AMPK activity, mutated in Peutz-Jeghers SyndromeRaptor: regulatory associated protein of mTORGL(mammalian)or LST8 (yeast)
![Page 19: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/19.jpg)
![Page 20: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/20.jpg)
![Page 21: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/21.jpg)
TOR downstream pathway
S6K: p70 S6 kinaseS6 protein: 40S ribosomal protein, drive 5’ TOP (terminal oligopyrimidine tract) mRNA translation4EBP1: eIF4E binding proteineIF4E: eukaryotic translation initiation factor 4E recognizes the 5’ end cap of mRNA, increase key growth-promoting proteins, cyclin D1, c-Myccdks: cyclin-dependent kinasepRb: protein retinoblastoma ( 眼癌 )PP2A: protein phosphatase 2A
![Page 22: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/22.jpg)
![Page 23: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/23.jpg)
![Page 24: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/24.jpg)
![Page 25: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/25.jpg)
TOR-binding proteins in yeastTORC1: AVO1, AVO2, AVO3, TOR2, LST8 controls actin organization, not a rapamycin targetTORC2: TOR1, TOR2, KOG1, LST8
![Page 26: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/26.jpg)
![Page 27: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/27.jpg)
TOR-binding proteins in mammalian cellraptor: regulatory associated protein of mTORGL: mammalian LST8,
![Page 28: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/28.jpg)
Raptor: regulatory associated protein of mTOR
![Page 29: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/29.jpg)
TOR functionBrain development learning and memory formationapoptosis
![Page 30: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/30.jpg)
TOR inhibit autophagy
![Page 31: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/31.jpg)
TOR and apoptosis
![Page 32: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/32.jpg)
TOR and apoptosis
![Page 33: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/33.jpg)
TOR and diseases
cancer heart hypertrophymuscular atrophyHamartoma syndromesInherited human dieases
![Page 34: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/34.jpg)
TOR and Cancers
![Page 35: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/35.jpg)
mTOR and Hamartoma syndromes
![Page 36: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/36.jpg)
Tor andInherited human dieases
![Page 37: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/37.jpg)
Future directions
TOR deficiency in C. elegans doubles lifespan, whether TOR controls lifespan in mammals ?How TOR senses and is activated by the presence of nutrients such as amino acid?Downstream targets and cellular processes that are regulated by TORRole of TOR in apoptosis?Understanding TOR signaling in neurons and muscle cells lead to new therapy for muscular wasting and memory impairmentTOR-binding proteins, gel filtration 2M
![Page 38: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/38.jpg)
![Page 39: TOR ( target of rapamycin) signaling Apr 4, 2005](https://reader033.vdocuments.us/reader033/viewer/2022042821/56649cec5503460f949b81f2/html5/thumbnails/39.jpg)